Abstract:Cancer therapy targets specific metabolic pathways or a single gene. This may result in low therapeutic effects due to drug selectivity and drug resistance. Recent studies revealed that the mitochondrial membrane potential and transmembrane permeability of cancerous mitochondria are differed from normal mitochondria. Thus, chemotherapy targeting cancerous mitochondria could be an innovative and competent strategy for cancer therapy. Previously, our work with a novel group of mitochondria targeting small molecules presented promising inhibitory capability toward various cancer cell lines and suppressed adenosine triphosphate (ATP) generation. Therefore, it is critical to understand the anticancer effect and targeting mechanism of these small molecules. This study investigated the inhibitory activity of mitochondria targeting small molecules with human cervical cancer cells - HeLa to further explore their therapeutic potential. HeLa cells were exposed to 10 mu M of syn-thesized compounds and presented elevation in intracellular reactive oxygen species (ROS) level, impaired mitochondrial membrane potential and upregulation of apoptosis as well as necrosis. In vivo, HeLa cell tumor-bearing BALB/c nude mice were treated with mitochondria targeting small molecules for 12 days consecu-tively. Throughout this chemotherapy study, no deleterious side effects nor the appearance of toxicity was observed. Furthermore, mitochondria targeting small molecules treated groups exhibited significant down-regulation with both tumor volume and tumor weight compared to the Doxorubicin (DOX) treated group. Thus, inhibition of mitochondrial ATP synthesis, activation of intracellular ROS production, down-regulation of mitochondrial membrane potential and upregulation of apoptosis and necrosis rates are the indications of cancer therapy. In this work, we examined the anticancer capability of four mitochondria targeting small molecules in vitro and in vivo, and demonstrated a novel therapeutic approach in cancer therapy with tremendous potential.

Mitochondria-Shaping Proteins and Chemotherapy

Mitochondria Targeting as an Effective Strategy for Cancer Therapy

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

Research Progress on Mitochondria Regulating Tumor Immunity.

Progress in the Study of Anti-Tumor Drugs Targeting Mitochondria

Mitochondrial integration and ovarian cancer chemotherapy resistance

Targeting the Mitochondria with Pseudo- Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment

The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy

Mitochondria As a Target in Cancer Treatment

Targeting Cancer Cell Mitochondria As a Therapeutic Approach.

Mitochondria: a new intervention target for tumor invasion and metastasis

Small Mitochondria-Targeting Molecules As Anti-Cancer Agents

Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria

Mitochondrial Immune Regulation and Anti-Tumor Immunotherapy Strategies Targeting Mitochondria

An Overview: The Diversified Role of Mitochondria in Cancer Metabolism

Three-dimensional analysis of mitochondria in a patient-derived xenograft model of triple negative breast cancer reveals mitochondrial network remodeling following chemotherapy treatments

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

Biological Evaluation of Mitochondria Targeting Small Molecules As Potent Anticancer Drugs.

Post-translational Modifications on Mitochondrial Metabolic Enzymes in Cancer

Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy

Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer